First leishmaniasis vaccine enters phase one trial as disease spreads to US

MedicalXpress | июн 06, 2026

A phase 1 clinical trial testing the safety of a leishmaniasis vaccine is set to begin in the coming months—the first vaccine created to protect against the disfiguring skin disease common in tropical regions of the world and gaining ground in the United States.